{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:41Z","timestamp":1791314381236,"version":"4.3.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T00:00:00Z","timestamp":1345420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Seoul R&D Program","award":["#10548"],"award-info":[{"award-number":["#10548"]}]},{"name":"Korea Food & Drug Administration","award":["S-11-04-2-SJV-993-0-H"],"award-info":[{"award-number":["S-11-04-2-SJV-993-0-H"]}]},{"name":"Korea Health Technology R&D Project"},{"name":"Ministry of Health & Welfare","award":["A111016"],"award-info":[{"award-number":["A111016"]}]},{"name":"Basic Science Research Program through the National Research Foundation of Korea"},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"crossref","award":["2012R1A1A2006827"],"award-info":[{"award-number":["2012R1A1A2006827"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Republic of Korea"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Induced pluripotent stem cells (iPSCs) generated from somatic cells of patients can be used to model different human diseases. They may also serve as sources of transplantable cells that can be used in novel cell therapies. Here, we analyzed neuronal properties of an iPSC line derived from a patient with a juvenile form of Huntington's disease (HD) carrying 72 CAG repeats (HD-iPSC). Although its initial neural inducing activity was lower than that of human embryonic stem cells, we found that HD-iPSC can give rise to GABAergic striatal neurons, the neuronal cell type that is most susceptible to degeneration in HD. We then transplanted HD-iPSC-derived neural precursors into a rat model of HD with a unilateral excitotoxic striatal lesion and observed a significant behavioral recovery in the grafted rats. Interestingly, during our in vitro culture and when the grafts were examined at 12 weeks after transplantation, no aggregate formation was detected. However, when the culture was treated with a proteasome inhibitor (MG132) or when the cells engrafted into neonatal brains were analyzed at 33 weeks, there were clear signs of HD pathology. Taken together, these results indicate that, although HD-iPSC carrying 72 CAG repeats can form GABAergic neurons and give rise to functional effects in vivo, without showing an overt HD phenotype, it is highly susceptible to proteasome inhibition and develops HD pathology at later stages of transplantation. These unique features of HD-iPSC will serve as useful tools to study HD pathology and develop novel therapeutics.<\/jats:p>","DOI":"10.1002\/stem.1135","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T16:28:17Z","timestamp":1337876897000},"page":"2054-2062","source":"Crossref","is-referenced-by-count":176,"title":["Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient-Derived Induced Pluripotent Stem Cells"],"prefix":"10.1093","volume":"30","author":[{"given":"Iksoo","family":"Jeon","sequence":"first","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayeon","family":"Lee","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Li","sequence":"additional","affiliation":[{"name":"Neuronal Survival Unit,, Wallenberg Neuroscience Center, Lund University, Lund, Sweden"},{"name":"Neural Plasticity and Repair Unit, Wallenberg Neuroscience Center, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Hyun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA"},{"name":"Department of Genetics, Yale University School of Medicine, New Haven, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Sun","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Integrative Bioscience and Biotechnology, Pohang University of Science and Technology, Pohang, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisook","family":"Moon","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Han","family":"Shim","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunggab","family":"Choi","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Jeong","family":"Chang","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Kwon","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hun","family":"Oh","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ah","family":"Shin","sequence":"additional","affiliation":[{"name":"Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Sook","family":"Kim","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Tae","family":"Do","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ryul","family":"Lee","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manho","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Seoul National University, College of Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Sun","family":"Kang","sequence":"additional","affiliation":[{"name":"Adult Stem Cell Research Center, College of Veterinary Medicine, Seoul National University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Q.","family":"Daley","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Brundin","sequence":"additional","affiliation":[{"name":"Neuronal Survival Unit,, Wallenberg Neuroscience Center, Lund University, Lund, Sweden"},{"name":"Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihwan","family":"Song","sequence":"additional","affiliation":[{"name":"CHA Stem Cell Institute, CHA University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,8,20]]},"reference":[{"key":"2022011204221399500_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BST0370323","article-title":"Medium spiny neurons for transplantation in Huntington's disease","volume":"37","author":"Kelly","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"2022011204221399500_bib2","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington's disease after neural transplantation","volume":"356","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Lancet"},{"key":"2022011204221399500_bib3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","article-title":"Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475","volume":"73","author":"Rosser","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022011204221399500_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.expneurol.2009.12.005","article-title":"Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation","volume":"222","author":"Gallina","year":"2010","journal-title":"Exp Neurol"},{"key":"2022011204221399500_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/75705","article-title":"Cell replacement therapies for central nervous system disorders","volume":"3","author":"Bj\u00f6rklund","year":"2000","journal-title":"Nat Neurosci"},{"key":"2022011204221399500_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2006.11.007","article-title":"Stem cell transplantation for Huntington's disease","volume":"203","author":"Dunnett","year":"2007","journal-title":"Exp Neurol"},{"key":"2022011204221399500_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"2022011204221399500_bib8","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nprot.2008.92","article-title":"Generation of human-induced pluripotent stem cells","volume":"3","author":"Park","year":"2008","journal-title":"Nat Protoc"},{"key":"2022011204221399500_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0896-6273(00)00083-0","article-title":"Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity","volume":"28","author":"Kawasaki","year":"2000","journal-title":"Neuron"},{"key":"2022011204221399500_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp Neurol"},{"key":"2022011204221399500_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0270(91)90048-5","article-title":"The \u201cstaircase test\u201d: A measure of independent forelimb reaching and grasping abilities in rats","volume":"36","author":"Montoya","year":"1991","journal-title":"J Neurosci Methods"},{"key":"2022011204221399500_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res"},{"key":"2022011204221399500_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1634\/stemcells.2004-0365","article-title":"Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells","volume":"23","author":"Yan","year":"2005","journal-title":"Stem Cells"},{"key":"2022011204221399500_bib14","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/brain\/awn149","article-title":"A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats","volume":"131","author":"Mukhida","year":"2008","journal-title":"Brain"},{"key":"2022011204221399500_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.stem.2011.04.002","article-title":"miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells","volume":"8","author":"Kim","year":"2011","journal-title":"Cell Stem Cell"},{"key":"2022011204221399500_bib16","doi-asserted-by":"crossref","first-page":"16707","DOI":"10.1073\/pnas.0808488105","article-title":"Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats","volume":"105","author":"Aubry","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011204221399500_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stem.2012.01.021","article-title":"Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid lesioned mice","volume":"10","author":"Ma","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022011204221399500_bib18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0306-4522(96)00238-2","article-title":"DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease","volume":"74","author":"Nakao","year":"1996","journal-title":"Neuroscience"},{"key":"2022011204221399500_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/096368979600500603","article-title":"A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures, and in vivo grafts","volume":"5","author":"Fricker","year":"1996","journal-title":"Cell Transplant"},{"key":"2022011204221399500_bib20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/378398a0","article-title":"A huntingtin-associated protein enriched in brain with implications for pathology","volume":"378","author":"Li","year":"1995","journal-title":"Nature"},{"key":"2022011204221399500_bib21","article-title":"Protein aggregates in Huntington's disease","author":"Arrasate","year":"2011","journal-title":"Exp Neurol"},{"key":"2022011204221399500_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1193","article-title":"Characterization of human Huntington's disease cell model from induced pluripotent stem cells","volume":"2","author":"Zhang","year":"2010","journal-title":"PLoS Curr"},{"key":"2022011204221399500_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2011.12.042","article-title":"The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity","volume":"46","author":"Camnasio","year":"2012","journal-title":"Neurobiol Dis"},{"key":"2022011204221399500_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.stem.2009.05.023","article-title":"Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells","volume":"5","author":"Zou","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2022011204221399500_bib25","first-page":"77","article-title":"Cellular therapy and induced neuronal replacement for Huntington's disease","author":"Benraiss","year":"2011"},{"key":"2022011204221399500_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mcn.2011.12.001","article-title":"Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin","volume":"49","author":"Olson","year":"2012","journal-title":"Cell Mol Neurosci"},{"key":"2022011204221399500_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12035-011-8219-8","article-title":"Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease","volume":"45","author":"Olson","year":"2012","journal-title":"Mol Neurobiol"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.1135","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.1135","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/stem.1135","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/30\/9\/2054\/41978013\/stmcls_30_9_2054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/30\/9\/2054\/41978013\/stmcls_30_9_2054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:47:23Z","timestamp":1642560443000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/30\/9\/2054-2062\/6404651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,20]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,8,20]]},"published-print":{"date-parts":[[2012,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/stem.1135","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,9,1]]},"published":{"date-parts":[[2012,8,20]]}}}